We founded Stimvia in 2014 (these days as Tesla Medical) as a spin-off of the Second Faculty of Medicine, Charles University in Prague.
We continued working on a research project of novel neuromodulation therapy for Overactive bladder treatment beginning in 2012. The body of the research was realised by the Urological department of the Motol University Hospital in Prague (one of the largest hospitals in Europe).
Since 2018, Stimvia is a fully independent company. The IP rights to our original technical solution and know-how are fully transferred from Charles University in Prague.
Meet the team
Prof. Jan Krhut, MD. Ph.D.
Former Head of Department of Urology, University Hospital Ostrava. Scientific Secreatry of Czech Urological Sociaty, consultant of many pharmaceutical and medtech startups and companies, participated in dozens of clinical trials of new drugs and medical devices aimed at the treatment of OAB
Roman Dvořák, MD.
He has more than 20 years of experience in research and development of new pharmaceutical and medical devices. Most of the time he worked for big pharmaceutical companies in the US, supervising the planning and execution of clinical trials. Over the last decade he focused on Biotechnology and MedTech startups.
Lukáš Peter, Ph.D.
Almost 6 years of experience in regulatory affairs of medical devices, 4 years of experience in medical devices market access across the EU and US (risk classes I, IIa, IIb). He has 6 years of experience in R&D of medical devices. Project leader of several projects across the EU.
Our company has long-term cooperation with institutions: